ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1203

Patient Satisfaction and Outcomes of a NOVEL Ankylosing Spondylitis Education and Self-Management Project

Jean McQuade1, Christina Johnston2, Charles Inderjeeth3,4,5,6, Kathy Briffa7, Jack Edelman8, Nicola Cook9 and Warren Raymond10, 1Arthritis WA, Wembley, Australia, 2Arthritis and Osteoporosis WA, Perth, Austria, 3Rehabiltation and Aged care and Rheumatology, Sir Charles Gairdner Hospital and University of Western Australia, Nedlands, Australia, 4North Metropolitan Health Service, University of Western Australia, Perth, WA, Australia, 5Subiaco Rheumatology Clinic, Subiaco, Australia, 6Linear Clinical Research Ltd, Perth, Australia, 7School of Physiotherapy and Exercise Science, Curtin University, Perth, Australia, 8Rheumatology, Sir Charles Gairdner Hospital, Perth, Australia, 9Royal Perth Hospital, Perth, Australia, 10Rheumatology and Geriatric Medicine, Sir Charles Gairdner Hospital and University of Western Australia, Nedlands, Australia

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Ankylosing spondylitis (AS), Compliance, Health outcome, patient engagement and self-management

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: Education Poster (ARHP): Education/Community Programs

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

 

Background/Purpose : Disease specific self-management interventions are rare. After a needs assessment, focus group discussions, and Plan, Do, Study, Act (PDSA) model we developed and tested the Self Management for Ankylosing Spondylitis (SMAS) program, for people with Ankylosing Spondylitis (AS).  We examined the benefits of an SMSA program for people with AS regarding change in health status, quality of life, and disease activity.

 

Methods: 134 people were recruited in this case cohort intervention. Exclusion criteria: <18yo; non-English speaking; co-morbid inflammatory musculoskeletal disease; and/or visual, auditory, or cognitive impairment. Participants attended a weekly 2.5 hour self-management education session facilitated by same two health professionals over 6 weeks. The scripted content included multidimensional strategies including stretches; and optional 7th week supervised exercise class.

 

Demographic, AS disease management characteristics, medication patterns, and outcomes were measured at baseline, 6 weeks, 3 and 6 months using repeated measures ANOVA for: back pain (VAS), fatigue (MAF), anxiety and depression (HAD), health distress (HDq), fatigue severity scale (FSS), pain self-efficacy (PSEQ), quality of life (SF-36) and Evaluating Ankylosing Spondylitis Qol (EASIQol), global perceived health (GPH), patients disease global assessment (PDGA).  AS outcomes were analysed using repeated measures ANOVA for: Bath Ankylosing Spondylitis – Global, Disease Activity Index, and Functional Index (BAS-G, BASDAI, & BASFI), and Ankylosing Spondylitis QoL (ASQol).

 

Results: At baseline, 43.3% were male, and the mean age was 47.2 ± 15.1 years. The median time to AS diagnosis from the index symptom experience was 3 years with an IQR (1-6). The BAS-G improved between baseline and 3 months (p=0.011) and were sustained at 6 months (p=0.039). The BASDAI improved between baseline and 3 months (p=0.01) and were sustained at 6 months (p=0.009). The ASQol improved between baseline and 6 months (p=0.051). A positive trend were seen for the MAFs GFI, back pain (i.e. nocturnal and total), and the PDGA over the 6 months although these trends were not statistically significant. The composite SF-36 (physical and mental), HADs, HDq, FSS, composite Easiqol (physical, disease activity, wellbeing, and social), PSEQ demonstrated no improvement over the study. There was no significant change in medication usage over the 6 months.

 

 

Conclusion:

SMAS for AS is independently effective in improving AS specific Disease activity, but global QOL scores did not change.

 

 

Table 1: Repeated Measures ANOVA for Quality of Life and Disease Activity tools over time.

Repeated Measures ANOVA

Baseline

WK6

WK6-BL

3MO

3M-BL

6MO

6MO-BL

Within-Subjects Contrasts

 

Mean (SE)

Mean (SE)

p-value

Mean (SE)

p-value

Mean (SE)

p-value

p-value

AS Specific Tools

BAS-G Score

6.09 (0.40)

5.83 (0.36)

0.548

4.89 (0.37)

0.011

5.03 (0.40)

0.039

0.004

BASDAI

5.30 (0.36)

4.83 (0.37)

0.107

4.36 (0.35)

0.01

4.30 (0.37)

0.009

0.005

AS Qol

8.83 (1.08)

8.17 (1.00)

0.409

7.50 (0.88)

0.104

7.03 (1.01)

0.051

0.059

BASFI

4.06 (0.40)

4.03 (0.34)

0.94

3.62 (0.31)

0.118

3.80 (0.40)

0.446

0.266

General Intervention Assessments

MAFs – GFI

26.14(2.33)

26.50 (2.43)

0.853

23.91 (2.67)

0.333

21.79 (2.67)

0.081

0.06

Back Pain Nocturnal

4.72 (0.41)

4.10 (0.41)

0.142

4.28 (0.42)

0.317

3.97 (0.43)

0.092

0.151

Back Pain Total

5.59 (0.45)

5.21 (0.38)

0.383

4.90 (0.36)

0.091

4.59 (0.46)

0.076

0.143

PDGA

5.24 (0.38)

5.07 (0.42)

0.634

4.66 (0.39)

0.176

4.55 (0.42)

0.081

0.246

SF 36 (Composite)

102.24 (2.07)

103.52 (1.74)

0.429

103.59 (1.59)

0.446

104.31 (1.76)

0.265

0.552

HADS

14.90 (1.62)

14.83 (1.64)

0.962

14.52 (1.43)

0.799

13.69 (1.54)

0.417

0.741

HDq

2.35 (0.25)

2.30 (0.27)

0.858

2.15 (0.26)

0.443

2.00 (0.26)

0.172

0.396

FSS

40.88 (1.87)

41.86 (1.69)

0.517

No Data

No Data

41.29 (1.93)

0.79

0.79

EasiQol (Composite)

35.78 (6.04)

36.11 (3.19)

0.950

30.44 (3.86)

0.228

30.33 (6.18)

0.492

0.544

PSEQ

36.62 (2.51)

36.31 (2.20)

0.861

36.66 (1.97)

.987

37.17 (2.59)

0.832

0.978

 


Disclosure: J. McQuade, None; C. Johnston, None; C. Inderjeeth, None; K. Briffa, None; J. Edelman, None; N. Cook, None; W. Raymond, None.

To cite this abstract in AMA style:

McQuade J, Johnston C, Inderjeeth C, Briffa K, Edelman J, Cook N, Raymond W. Patient Satisfaction and Outcomes of a NOVEL Ankylosing Spondylitis Education and Self-Management Project [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/patient-satisfaction-and-outcomes-of-a-novel-ankylosing-spondylitis-education-and-self-management-project/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patient-satisfaction-and-outcomes-of-a-novel-ankylosing-spondylitis-education-and-self-management-project/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology